In English | En español
Questions About Cancer? 1-800-4-CANCER

NCI Drug Dictionary

  

malignant glioma tumor lysate-pulsed autologous dendritic cell vaccine 
A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with lysates from malignant glioma cells with potential immunostimulatory and antineoplastic activities. Upon administration, malignant glioma tumor lysate-pulsed autologous dendritic cell vaccine exposes the immune system to undefined malignant glioma tumor-associated antigens (TAAs), which may result in anti-tumoral cytotoxic T lymphocyte (CTL) and antibody responses against glioma cells and glioma cell lysis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)